Selected article for: "case management and report case"
Author: Berrichi, Samia; Bouayed, Zakaria; Berrajaa, Sara; Mezzeoui, Sanae EL.; Moujahid, Amal; Nasri, Siham; Bkiyar, Houssam; Skiker, Imane; Housni, Brahim
Title: Acute limb ischemia with concomitant splenic and renal infarcts: Thromboembolic events revealing COVID-19
  • Cord-id: q4yaaxlp
  • Document date: 2021_7_29
    • ID: q4yaaxlp
    Snippet: INTRODUCTION: Since December 2019, the coronavirus 19 (COVID-19) pandemic continues to spread worldwide and has caused millions of deaths. Although the main manifestation of the disease is acute respiratory distress syndrome, hypercoagulability resulting from hypoxemia leads to venous thromboembolism and arterial thrombosis, which have a fatal prognosis for COVID-19. CASE REPORT MANAGEMENT: We report the case of patient admitted to our unit for management of a concomitant limb ischemia, splenic
    Document: INTRODUCTION: Since December 2019, the coronavirus 19 (COVID-19) pandemic continues to spread worldwide and has caused millions of deaths. Although the main manifestation of the disease is acute respiratory distress syndrome, hypercoagulability resulting from hypoxemia leads to venous thromboembolism and arterial thrombosis, which have a fatal prognosis for COVID-19. CASE REPORT MANAGEMENT: We report the case of patient admitted to our unit for management of a concomitant limb ischemia, splenic and renal infarcts associated to a COVID-19 infection with favorable outcomes after thrombectomy and therapeutic doses of heparin. CONCLUSION: Systemic procoagulant manifestations related to a COVID-19 infection is a newly described phenomenon responsible of cardiovascular and neurological disorders.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and acute limb ischemia: 1, 2
    • abdominal pain and lmwh low molecular weight heparin: 1
    • abdominal pain and low molecular: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • abdominal pain and low mortality: 1, 2
    • abdominal pain and lung damage: 1
    • abdominal pain and macrophage activation: 1, 2, 3, 4
    • abnormal activity and acute limb: 1
    • active smoking and additional treatment: 1
    • active smoking and low mortality: 1
    • acute limb and additional treatment: 1
    • acute limb and lmwh low molecular weight heparin: 1, 2
    • acute limb and low molecular: 1, 2, 3, 4, 5, 6, 7, 8
    • acute limb and low molecular weight: 1, 2, 3, 4, 5, 6, 7, 8
    • acute limb and low molecular weight heparin: 1, 2, 3, 4, 5, 6, 7, 8
    • acute limb and low mortality: 1
    • acute limb and lung damage: 1
    • acute limb ischemia and additional treatment: 1